Takeda is committed to discovering and delivering life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on core therapeutic and business areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI), Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. https://www.takeda.com/en-ca/